作者
Seyed-Hesameddin Abbasi, Fahimeh Hosseini, Amirhossein Modabbernia, Mandana Ashrafi, Shahin Akhondzadeh
发表日期
2012/12/10
期刊
Journal of affective disorders
卷号
141
期号
2-3
页码范围
308-314
出版商
Elsevier
简介
BACKGROUND: It has been proposed that the mechanism of the antidepressant effect of celecoxib is linked to its anti-inflammatory action and particularly its inhibitory effect on pro-inflammatory cytokines (e.g. interleukin-6(IL-6)). We measured changes in serum IL-6 concentrations and depressive symptoms following administration of celecoxib in patients with major depressive disorder (MDD). METHODS: In a randomized double-blind placebo-controlled study, 40 patients with MDD and Hamilton Depression Rating Scale—17 items (Ham-D) score ≥18 were randomly assigned to either celecoxib (200mg twice daily) or placebo in addition to sertraline (200mg/day) for 6weeks. Outcome measures were serum IL-6 concentrations at baseline and week 6, and Ham-D scores at baseline and weeks 1, 2, 4, and 6. RESULTS: The celecoxib group showed significantly greater reduction in serum IL-6 concentrations (mean …
引用总数
20122013201420152016201720182019202020212022202320244223131234336272844212919